Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142147 |
| CAS No | NA |
| Mol.F. | C28H31ClN8O2 |
| Mol.Wt. | 547.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142148 |
| CAS No | 41286-73-1 |
| Mol.F. | C11H14N6O5 |
| Mol.Wt. | 310.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142149 |
| CAS No | NA |
| Mol.F. | C70H103N2O47S7 |
| Mol.Wt. | 1949.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142150 |
| CAS No | NA |
| Mol.F. | C70H110N2O47S7 |
| Mol.Wt. | 1956.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142151 |
| CAS No | NA |
| Mol.F. | C5H4N6O |
| Mol.Wt. | 164.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142152 |
| CAS No | NA |
| Mol.F. | C9H11N3O7 |
| Mol.Wt. | 273.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142153 |
| CAS No | NA |
| Mol.F. | C16H19N9O6 |
| Mol.Wt. | 433.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142154 |
| CAS No | NA |
| Mol.F. | C11H15N7O5 |
| Mol.Wt. | 325.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142155 |
| CAS No | NA |
| Mol.F. | C9H8N6O3 |
| Mol.Wt. | 248.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142156 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142157 |
| CAS No | NA |
| Mol.F. | C18H20N2O3 |
| Mol.Wt. | 312.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142158 |
| CAS No | 3006789-99-4 |
| Mol.F. | C9H12N2O4 |
| Mol.Wt. | 212.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142159 |
| CAS No | NA |
| Mol.F. | C9H10N2O4 |
| Mol.Wt. | 210.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142160 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142161 |
| CAS No | NA |
| Mol.F. | C15H14N2O4 |
| Mol.Wt. | 286.29g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142162 |
| CAS No | NA |
| Mol.F. | C10H14N2O4 |
| Mol.Wt. | 226.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |